Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.99576
Figure 5 Quality of life of the two groups.
A: Changes in energy before and after treatment; B: Changes in social functioning before and after treatment; C: Changes in role functioning before and after treatment; D: Changes in body functioning before and after treatment; E: Changes in mental health before and after treatment; F: Changes in overall health changes before and after treatment. aP < 0.05, bP < 0.01 in the inter-group comparison.
- Citation: Li D, Qiao F, Dai J, Xu M, Gong HY, Yang HM, Li JC, Huai D. Therapeutic effectiveness of intratympanic and retroauricular methylprednisolone sodium succinate for refractory sudden sensorineural hearing loss in diabetic patients. World J Diabetes 2025; 16(5): 99576
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/99576.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.99576